Joanna L. Conant

发表

Assessing the Accuracy of Spatiotemporal Epidemiological Models

Judith V. Douglas, James H. Kaufman, Barbara Jones, 2008, BioSecure.

Transition to Subspecialty Sign-Out at an Academic Institution and Its Advantages

Joanna L. Conant, P. Gibson, J. Bunn, 2017, Academic pathology.

Briefing : Method for electronics optimisation using a suite of fast specialist optimisation scenarios produced via an evolutionary algorithm

Joanna L. Conant, Liam Donnelly, Juli-Anne Gardner, 2005 .

BCR‐ABL1‐like B‐lymphoblastic leukemia/lymphoma: Review of the entity and detection methodologies

Joanna L. Conant, David R. Czuchlewski, 2019, International journal of laboratory hematology.

Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature

Joanna L. Conant, N. Zakai, Mary E Tang, 2016, Case reports in medicine.

Acquired BCR-ABL1 fusion and IDH1 clonal evolution following BCL2 inhibitor treatment in refractory acute myeloid leukemia.

Joanna L. Conant, Juli-Anne Gardner, Katherine A. Devitt, 2020, Leukemia research.

Sarcomatoid renal cell carcinoma is an example of epithelial–mesenchymal transition

Joanna L. Conant, K. Cooper, M. Evans, 2011, Journal of Clinical Pathology.

Molecular Pathways and Potential for Targeted Therapies in the Treatment of Early T-cell Precursor Acute Lymphoblastic Leukemia

Joanna L. Conant, Liam Donnelly, Juli-Anne Gardner, 2020, Advances in Molecular Pathology.

PAX stains in hematologic malignancies, a diagnostic pitfall: a comparative study evaluating monoclonal PAX8s, polyclonal PAX2, and PAX5

Joanna L. Conant, M. Desarno, M. Zenali, 2016, Journal of Hematopathology.

Clinicopathologic Features and Clinical Outcome Differences in De Novo Versus Secondary Histiocytic Sarcomas: A Multi‐institutional Experience and Review of the Literature

Joanna L. Conant, G. Siegal, D. Broadwater, 2018, Clinical lymphoma, myeloma & leukemia.

Lyme Disease Testing in a High-Incidence State: Clinician Knowledge and Patterns

Joanna L. Conant, P. Mead, C. Nelson, 2018, American journal of clinical pathology.

Isolated bone marrow gamma-delta T-Cell lymphoma: Another challenge to the WHO lymphoid neoplasm classification

Joanna L. Conant, D. Alejos, Katherine A. Devitt, 2023, Leukemia research reports.

Clinicopathologic Features and Clinical Outcome Differences in De Novo Versus Secondary Histiocytic Sarcomas: A Multi-institutional Experience and Review of the Literature

Joanna L. Conant, G. Siegal, D. Broadwater, 2018, Clinical Lymphoma Myeloma and Leukemia.

Discordant high‐grade B‐cell lymphoma with MYC and BCL6 rearrangements presenting as a pericardial effusion

Joanna L. Conant, Katherine A. Devitt, C. LaValley, 2021, International journal of laboratory hematology.

Myelodysplastic Syndrome with Excess Blasts 2 (MDS-EB-2): A Historical Overview and Review of Forthcoming Classifications.

Joanna L. Conant, Juli-Anne Gardner, Katherine A. Devitt, 2023, Journal of the Association of Genetic Technologists.